Amneal Pharmaceuticals Inc (AMRX)

14.66 -0.03%

Amneal Pharmaceuticals Inc (AMRX) is currently trading at $14.66. This represents a loss of 0.03% from the previous session. With a market capitalization of $4.63B, AMRX is a key component of the Health Care sector. Investors looking to trade AMRX should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade AMRX commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Amneal Pharmaceuticals Inc (AMRX) shows a bearish trend. Analysts are watching the 14.84 level closely.

Fundamentals
Mkt Cap4.63B
P/E Ratio0.0000
Volume254,767
Others Watching (By Market Cap)
RNA
Avidity Bioscie $72.75
+0.00% BAX
Baxter Internat $20.53
-0.48% EHC
Encompass Healt $104.53
-0.23% MDGL
Madrigal Pharma $440.57
+0.22% DVA
Davita Inc $146.80
-2.72%
60-Day Technical Chart
Advanced Charting

Need more indicators for AMRX? Use the world's #1 platform.

Open AMRX on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $15
Metric AMRX
-0.03% 		F
+1.23% 		LUNR
-16.88% 		SMR
-1.27%
Price $14.66 $14.38 $15.71 $13.28
Mkt Cap $4.63B $57.15B $3.21B $4.02B
- View → View → View →
Latest Headlines
Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now? Yahoo Finance • Feb 23, 2026 Amneal Pharmaceuticals, Inc. (AMRX) Added to S&P SmallCap 600 Index, Boosting Investor Visibility Finviz • Feb 18, 2026 Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026 GlobeNewswire • Jan 27, 2026 Amneal (Nasdaq: AMRX) gains FDA OK for epinephrine vials in $118M U.S. market Stock Titan • Dec 9, 2025 Is Amneal Pharmaceuticals (AMRX) a Great Value Stock Right Now? Yahoo Finance • Feb 5, 2026
● Gemini Agentic AI Analyst Insight for AMRX
Market Education
View All Articles →
External Research